Abstract
Malaria remains a major parasitic disease in the tropical and sub-tropical countries mainly due to dramatic increase in parasite lines resistant to commonly used anti-malarials. Characterization of novel metabolic pathways in the parasites and understanding their functional role is a prerequisite to design new anti-malarial strategies. Parasite proteases play key role in growth and differentiation of all the developmental stages across the parasite life cycle and present the most promising targets to develop new drugs against malaria. In Plasmodium falciparum genome database a total of 123 proteases are identified; these proteases belong to five different clans: Cysteine, Aspartic, Serine, Metallo-, and Threonine. Some of the most studied parasite proteases are those that are functional in the asexual blood stage cycle. Starting with the processing of key parasite ligand in merozoite, the invasive form of blood stage parasite, degradation of host hemoglobin in food-vacuole, regulation of levels of key metabolic pathways in cytosol and cellular organelles, degradation of misfolded and unused proteins, and rupture of host membrane for egress of daughter merozoites is mediated by these proteases. Here we discuss roles of some of the parasite proteases involved in various steps of the parasite intra-erythrocytic cycle.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Snow RW, Guerra CA, Noor AM et al (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214–217
Teixeira C, Gomes JR, Gomes P (2011) Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria. Curr Med Chem 18:1555–1572
Tschan S, Mordmuller B, Kun JF (2011) Threonine peptidases as drug targets against malaria. Expert Opin Ther Targets 15:365–378
McKerrow JH, Rosenthal PJ, Swenerton R et al (2008) Development of protease inhibitors for protozoan infections. Curr Opin Infect Dis 21:668–672
Wu Y, Wang X, Liu X et al (2003) Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. Genome Res 13:601–616
Cai H, Gu J, Wang Y (2010) Core genome components and lineage specific expansions in malaria parasites plasmodium. BMC Genomics 11(Suppl 3):S13
Rosenthal PJ (2011) Falcipains and other cysteine proteases of malaria parasites. Adv Exp Med Biol 712:30–48
Brady RL, Cameron A (2004) Structure-based approaches to the development of novel anti-malarials. Curr Drug Targets 5:137–149
Werbovetz KA (2000) Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis. Curr Med Chem 7:835–860
Cowman AF, Crabb BS (2006) Invasion of red blood cells by malaria parasites. Cell 124:755–766
Blackman MJ (2000) Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic targets. Curr Drug Targets 1:59–83
Singh S, Alam MM, Pal-Bhowmick I et al (2010) Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog 6:e1000746
Alexander DL, Mital J, Ward GE et al (2005) Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog 1:e17
Besteiro S, Dubremetz JF, Lebrun M (2011) The moving junction of apicomplexan parasites: a key structure for invasion. Cell Microbiol 13:797–805
Holder AA (1988) The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy 41:72–97
Stafford WH, Blackman MJ, Harris A et al (1994) N-terminal amino acid sequence of the Plasmodium falciparum merozoite surface protein-1 polypeptides. Mol Biochem Parasitol 66:157–160
Blackman MJ, Holder AA (1992) Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. Mol Biochem Parasitol 50:307–315
Pachebat JA, Ling IT, Grainger M et al (2001) The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7. Mol Biochem Parasitol 117:83–89
Pachebat JA, Kadekoppala M, Grainger M et al (2007) Extensive proteolytic processing of the malaria parasite merozoite surface protein 7 during biosynthesis and parasite release from erythrocytes. Mol Biochem Parasitol 151:59–69
Dutta S, Haynes JD, Barbosa A et al (2005) Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Infect Immun 73:2116–2122
Treeck M, Zacherl S, Herrmann S et al (2009) Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process. PLoS Pathog 5:e1000322
Howell SA, Withers-Martinez C, Kocken CH et al (2001) Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem 276: 31311–31320
Howell S, Well I, Fleck S et al (2003) A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. J Biol Chem 278: 23890–23898
Barale JC, Blisnick T, Fujioka H et al (1999) Plasmodium falciparum subtilisin-like protease 2, a merozoite candidate for the merozoite surface protein 1-42 maturase. Proc Natl Acad Sci USA 96:6445–6450
Hackett F, Sajid M, Withers-Martinez C et al (1999) PfSUB-2: a second subtilisin-like protein in Plasmodium falciparum merozoites. Mol Biochem Parasitol 103:183–195
Gardner MJ, Hall N, Fung E et al (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498–511
Blackman MJ, Fujioka H, Stafford WH et al (1998) A subtilisin-like protein in secretory organelles of Plasmodium falciparum merozoites. J Biol Chem 273:23398–23409
Agarwal S, Singh MK, Garg S et al (2012) Ca(2+) -mediated exocytosis of subtilisin-like protease 1: a key step in egress of Plasmodium falciparum merozoites. Cell Microbiol, DOI: 10.1111/cmi.12086
Yeoh S, O’Donnell RA, Koussis K et al (2007) Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. Cell 131:1072–1083
Koussis K, Withers-Martinez C, Yeoh S et al (2009) A multifunctional serine protease primes the malaria parasite for red blood cell invasion. EMBO J 28:725–735
Silmon de Monerri NC, Flynn HR, Campos MG et al (2011) Global identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease. Infect Immun 79:1086–1097
Arastu-Kapur S, Ponder EL, Fonovic UP et al (2008) Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat Chem Biol 4:203–213
Blackman MJ (2008) Malarial proteases and host cell egress: an ‘emerging’ cascade. Cell Microbiol 10:1925–1934
Harris PK, Yeoh S, Dluzewski AR et al (2005) Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog 1:241–251
Green JL, Hinds L, Grainger M et al (2006) Plasmodium thrombospondin related apical merozoite protein (PTRAMP) is shed from the surface of merozoites by PfSUB2 upon invasion of erythrocytes. Mol Biochem Parasitol 150:114–117
Uzureau P, Barale JC, Janse CJ et al (2004) Gene targeting demonstrates that the Plasmodium berghei subtilisin PbSUB2 is essential for red cell invasion and reveals spontaneous genetic recombination events. Cell Microbiol 6:65–78
Alam A, Bhatnagar RK, Chauhan VS (2012) Expression and characterization of catalytic domain of Plasmodium falciparum subtilisin-like protease 3. Mol Biochem Parasitol 183:84–89
Miller SK, Good RT, Drew DR et al (2002) A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. J Biol Chem 277:47524–47532
McCoubrie JE, Miller SK, Sargeant T et al (2007) Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Infect Immun 75:5565–5574
Chulay JD, Lyon JA, Haynes JD et al (1987) Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. J Immunol 139:2768–2774
Higgins DG, McConnell DJ, Sharp PM (1989) Malarial proteinase? Nature 340:604
Hodder AN, Drew DR, Epa VC et al (2003) Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. J Biol Chem 278:48169–48177
Pang XL, Mitamura T, Horii T (1999) Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect Immun 67:1821–1827
Li J, Mitamura T, Fox BA et al (2002) Differential localization of processed fragments of Plasmodium falciparum serine repeat antigen and further processing of its N-terminal 47 kDa fragment. Parasitol Int 51:343–352
Delplace P, Bhatia A, Cagnard M et al (1988) Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites. Biol Cell 64:215–221
Ruecker A, Shea M, Hackett F et al (2012) Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte. J Biol Chem 287:37949–37963
Nwagwu M, Haynes JD, Orlandi PA et al (1992) Plasmodium falciparum: chymotryptic-like proteolysis associated with a 101-kDa acidic-basic repeat antigen. Exp Parasitol 75:399–414
Kushwaha A, Rao PP, Duttu VS et al (2000) Expression and characterisation of Plasmodium falciparum acidic basic repeat antigen expressed in Escherichia coli. Mol Biochem Parasitol 106:213–224
Lopera TM, Restrepo M, Blair S et al (1998) Humoral immune response to the anti-malaria vaccine SPf66 in the Colombian Atrato River region. Mem Inst Oswaldo Cruz 93:495–500
Curtidor H, Urquiza M, Suarez J et al (2001) Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine 19:4496–4504
Vargas-Serrato E, Barnwell JW, Ingravallo P et al (2002) Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum. Mol Biochem Parasitol 120:41–52
Mills KE, Pearce JA, Crabb BS et al (2002) Truncation of merozoite surface protein 3 disrupts its trafficking and that of acidic-basic repeat protein to the surface of Plasmodium falciparum merozoites. Mol Microbiol 43:1401–1411
Zhou XW, Blackman MJ, Howell SA et al (2004) Proteomic analysis of cleavage events reveals a dynamic two-step mechanism for proteolysis of a key parasite adhesive complex. Mol Cell Proteomics 3:565–576
Howell SA, Hackett F, Jongco AM et al (2005) Distinct mechanisms govern proteolytic shedding of a key invasion protein in apicomplexan pathogens. Mol Microbiol 57:1342–1356
Baker RP, Wijetilaka R, Urban S (2006) Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. PLoS Pathog 2:e113
O’Donnell RA, Hackett F, Howell SA et al (2006) Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite. J Cell Biol 174:1023–1033
Vera IM, Beatty WL, Sinnis P et al (2011) Plasmodium protease ROM1 is important for proper formation of the parasitophorous vacuole. PLoS Pathog 7:e1002197
Srinivasan P, Coppens I, Jacobs-Lorena M (2009) Distinct roles of Plasmodium rhomboid 1 in parasite development and malaria pathogenesis. PLoS Pathog 5:e1000262
Rosenthal PJ, Sijwali PS, Singh A et al (2002) Cysteine proteases of malaria parasites: targets for chemotherapy. Curr Pharm Des 8:1659–1672
Greenbaum DC, Baruch A, Grainger M et al (2002) A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298:2002–2006
Sijwali PS, Kato K, Seydel KB et al (2004) Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc Natl Acad Sci USA 101:8721–8726
Banyal HS, Misra GC, Gupta CM et al (1981) Involvement of malarial proteases in the interaction between the parasite and host erythrocyte in Plasmodium knowlesi infections. J Parasitol 67:623–626
Wickham ME, Culvenor JG, Cowman AF (2003) Selective inhibition of a two-step egress of malaria parasites from the host erythrocyte. J Biol Chem 278:37658–37663
Le Bonniec S, Deregnaucourt C, Redeker V et al (1999) Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem 274:14218–14223
Dhawan S, Dua M, Chishti AH et al (2003) Ankyrin peptide blocks falcipain-2-mediated malaria parasite release from red blood cells. J Biol Chem 278:30180–30186
Dasaradhi PV, Korde R, Thompson JK et al (2007) Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 156:12–23
Aoki S, Li J, Itagaki S et al (2002) Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J Biol Chem 277:47533–47540
Dua M, Raphael P, Sijwali PS et al (2001) Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. Mol Biochem Parasitol 116:95–99
Hanspal M, Dua M, Takakuwa Y et al (2002) Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100:1048–1054
Dasaradhi PV, Mohmmed A, Kumar A et al (2005) A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression. Biochem Biophys Res Commun 336:1062–1068
Omara-Opyene AL, Moura PA, Sulsona CR et al (2004) Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy. J Biol Chem 279:54088–54096
Sijwali PS, Rosenthal PJ (2004) Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA 101:4384–4389
Liu J, Gluzman IY, Drew ME et al (2005) The role of Plasmodium falciparum food vacuole plasmepsins. J Biol Chem 280:1432–1437
Sijwali PS, Koo J, Singh N et al (2006) Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Mol Biochem Parasitol 150:96–106
Chandramohanadas R, Davis PH, Beiting DP et al (2009) Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells. Science 324:794–797
Singh N, Sijwali PS, Pandey KC et al (2006) Plasmodium falciparum: biochemical characterization of the cysteine protease falcipain-2′. Exp Parasitol 112:187–192
Chugh M, Sundararaman V, Kumar S et al (2013) Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc Natl Acad Sci USA 110:5392–5397
Murata CE, Goldberg DE (2003) Plasmodium falciparum falcilysin: a metalloprotease with dual specificity. J Biol Chem 278:38022–38028
Francis SE, Banerjee R, Goldberg DE (1997) Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J Biol Chem 272:14961–14968
Ponpuak M, Klemba M, Park M et al (2007) A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast. Mol Microbiol 63:314–334
Francis SE, Gluzman IY, Oksman A et al (1994) Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J 13:306–317
Banerjee R, Liu J, Beatty W et al (2002) Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci USA 99(2):990–995
Silva AM, Lee AY, Gulnik SV et al (1996) Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc Natl Acad Sci USA 93:10034–10039
Moon RP, Tyas L, Certa U et al (1997) Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur J Biochem 244:552–560
Haque TS, Skillman AG, Lee CE et al (1999) Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J Med Chem 42:1428–1440
Nezami A, Luque I, Kimura T et al (2002) Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. Biochemistry 41:2273–2280
Skinner-Adams TS, McCarthy JS, Gardiner DL et al (2004) Antiretrovirals as antimalarial agents. J Infect Dis 190:1998–2000
Parikh S, Gut J, Istvan E et al (2005) Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 49:2983–2985
Savarino A, Cauda R, Cassone A (2005) Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors. J Infect Dis 191:1381–1382, author reply 1382–1383
Shenai BR, Sijwali PS, Singh A et al (2000) Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem 275:29000–29010
Dahl EL, Rosenthal PJ (2005) Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. Mol Biochem Parasitol 139:205–212
Mohmmed A, Dasaradhi PV, Bhatnagar RK et al (2003) In vivo gene silencing in Plasmodium berghei - a mouse malaria model. Biochem Biophys Res Commun 309:506–511
Powers JC, Asgian JL, Ekici OD et al (2002) Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem Rev 102:4639–4750
Rosenthal PJ, Wollish WS, Palmer JT et al (1991) Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest 88:1467–1472
Gibbons P, Verissimo E, Araujo NC et al (2010) Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: toward combination chemotherapy of malaria through a single chemical entity. J Med Chem 53:8202–8206
Liu Y, Lu WQ, Cui KQ et al (2012) Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors. Arch Pharm Res 35:1525–1531
Mane UR, Gupta RC, Nadkarni SS et al (2013) Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review. Expert Opin Ther Pat 23:165–187
Rizzi L, Sundararaman S, Cendic K et al (2011) Design and synthesis of protein-protein interaction mimics as Plasmodium falciparum cysteine protease, falcipain-2 inhibitors. Eur J Med Chem 46:2083–2090
Curley GP, O’Donovan SM, McNally J et al (1994) Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi and Plasmodium berghei. J Eukaryot Microbiol 41:119–123
Gavigan CS, Dalton JP, Bell A (2001) The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol 117:37–48
Stack CM, Lowther J, Cunningham E et al (2007) Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development. J Biol Chem 282:2069–2080
Florent I, Derhy Z, Allary M et al (1998) A Plasmodium falciparum aminopeptidase gene belonging to the M1 family of zinc-metallopeptidases is expressed in erythrocytic stages. Mol Biochem Parasitol 97:149–160
Allary M, Schrevel J, Florent I (2002) Properties, stage-dependent expression and localization of Plasmodium falciparum M1 family zinc-aminopeptidase. Parasitology 125:1–10
Dalal S, Klemba M (2007) Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum. J Biol Chem 282:35978–35987
Teuscher F, Lowther J, Skinner-Adams TS et al (2007) The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum. J Biol Chem 282:30817–30826
Poreba M, McGowan S, Skinner-Adams TS et al (2012) Fingerprinting the substrate specificity of M1 and M17 aminopeptidases of human malaria, Plasmodium falciparum. PLoS One 7:e31938
Dalal S, Ragheb DR, Klemba M (2012) Engagement of the S1, S1′ and S2′ subsites drives efficient catalysis of peptide bond hydrolysis by the M1-family aminopeptidase from Plasmodium falciparum. Mol Biochem Parasitol 183:70–77
Jones PM, Robinson MW, Dalton JP et al (2011) The Plasmodium falciparum malaria M1 alanyl aminopeptidase (PfA-M1): insights of catalytic mechanism and function from MD simulations. PLoS One 6:e28589
Skinner-Adams TS, Lowther J, Teuscher F et al (2007) Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds. J Med Chem 50:6024–6031
Harbut MB, Velmourougane G, Dalal S et al (2011) Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases. Proc Natl Acad Sci USA 108:E526–E534
Waller RF, McFadden GI (2005) The apicoplast: a review of the derived plastid of apicomplexan parasites. Curr Issues Mol Biol 7:57–79
Goodman CD, Su V, McFadden GI (2007) The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 152:181–191
Schlitzer M (2007) Malaria chemotherapeutics part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development. Chem Med Chem 2:944–986
Schlitzer M (2006) Selective enzyme inhibitor instead of an “iron-triggered cluster bomb”. Pharm Unserer Zeit 35:8–9
Dahl EL, Rosenthal PJ (2008) Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends Parasitol 24:279–284
Tschan S, Kreidenweiss A, Stierhof YD et al (2010) Mitochondrial localization of the threonine peptidase PfHslV, a ClpQ ortholog in Plasmodium falciparum. Int J Parasitol 40:1517–1523
Ramasamy G, Gupta D, Mohmmed A et al (2007) Characterization and localization of Plasmodium falciparum homolog of prokaryotic ClpQ/HslV protease. Mol Biochem Parasitol 152:139–148
Sousa MC, Trame CB, Tsuruta H et al (2000) Crystal and solution structures of an HslUV protease-chaperone complex. Cell 103:633–643
Rathore S, Jain S, Sinha D et al (2011) Disruption of a mitochondrial protease machinery in Plasmodium falciparum is an intrinsic signal for parasite cell death. Cell Death Dis 2:e231
Li Z, Lindsay ME, Motyka SA et al (2008) Identification of a bacterial-like HslVU protease in the mitochondria of Trypanosoma brucei and its role in mitochondrial DNA replication. PLoS Pathog 4:e1000048
Jain S, Rathore S, Asad M et al (2013) The prokaryotic ClpQ protease plays a key role in growth and development of mitochondria in Plasmodium falciparum. Cell Microbiol, DOI: 10.1111/cmi.12142
Ralph SA, van Dooren GG, Waller RF et al (2004) Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol 2:203–216
McConkey GA, Rogers MJ, McCutchan TF (1997) Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J Biol Chem 272:2046–2049
Lin Q, Katakura K, Suzuki M (2002) Inhibition of mitochondrial and plastid activity of Plasmodium falciparum by minocycline. FEBS Lett 515:71–74
Williamson DH, Preiser PR, Moore PW et al (2002) The plastid DNA of the malaria parasite Plasmodium falciparum is replicated by two mechanisms. Mol Microbiol 45:533–542
Chaubey S, Kumar A, Singh D et al (2005) The apicoplast of Plasmodium falciparum is translationally active. Mol Microbiol 56:81–89
Yeh E, DeRisi JL (2011) Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol 9:e1001138
van Dooren GG, Su V, D’Ombrain MC et al (2002) Processing of an apicoplast leader sequence in Plasmodium falciparum and the identification of a putative leader cleavage enzyme. J Biol Chem 277:23612–23619
El Bakkouri M, Rathore S, Calmettes C et al (2013) Structural insights into the inactive subunit of the apicoplast-localized caseinolytic protease complex of Plasmodium falciparum. J Biol Chem 288:1022–1031
Rathore S, Sinha D, Asad M et al (2010) A cyanobacterial serine protease of Plasmodium falciparum is targeted to the apicoplast and plays an important role in its growth and development. Mol Microbiol 77:873–890
Gille C, Goede A, Schloetelburg C et al (2003) A comprehensive view on proteasomal sequences: implications for the evolution of the proteasome. J Mol Biol 326:1437–1448
Mordmuller B, Fendel R, Kreidenweiss A et al (2006) Plasmodia express two threonine-peptidase complexes during asexual development. Mol Biochem Parasitol 148:79–85
Aminake MN, Mahajan A, Kumar V et al (2012) Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy. Bioorg Med Chem 20:5277–5289
Gantt SM, Myung JM, Briones MR et al (1998) Proteasome inhibitors block development of Plasmodium spp. Antimicrob Agents Chemother 42:2731–2738
Reynolds JM, El Bissati K, Brandenburg J et al (2007) Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B. BMC Clin Pharmacol 7:13
Kreidenweiss A, Kremsner PG, Mordmuller B (2008) Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon. Malar J 7:187
Prudhomme J, McDaniel E, Ponts N et al (2008) Marine actinomycetes: a new source of compounds against the human malaria parasite. PLoS One 3:e2335
Frickel EM, Quesada V, Muething L et al (2007) Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution. Cell Microbiol 9:1601–1610
Ponder EL, Albrow VE, Leader BA et al (2011) Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol 18:711–721
Ponder EL, Bogyo M (2007) Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa. Eukaryot Cell 6:1943–1952
Ponts N, Yang J, Chung DW et al (2008) Deciphering the ubiquitin-mediated pathway in apicomplexan parasites: a potential strategy to interfere with parasite virulence. PLoS One 3:e2386
Spork S, Hiss JA, Mandel K et al (2009) An unusual ERAD-like complex is targeted to the apicoplast of Plasmodium falciparum. Eukaryot Cell 8:1134–1145
Artavanis-Tsakonas K, Misaghi S, Comeaux CA et al (2006) Identification by functional proteomics of a deubiquitinating/deNeddylating enzyme in Plasmodium falciparum. Mol Microbiol 61:1187–1195
Le Roch KG, Johnson JR, Florens L et al (2004) Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res 14:2308–2318
Artavanis-Tsakonas K, Weihofen WA, Antos JM et al (2010) Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3. J Biol Chem 285:6857–6866
Issar N, Roux E, Mattei D et al (2008) Identification of a novel post-translational modification in Plasmodium falciparum: protein sumoylation in different cellular compartments. Cell Microbiol 10:1999–2011
Sharma S, Pradhan A, Chauhan VS et al (2005) Isolation and characterization of type I signal peptidase of different malaria parasites. J Biomed Biotechnol 2005:301–309
Tuteja R, Pradhan A, Sharma S (2008) Plasmodium falciparum signal peptidase is regulated by phosphorylation and required for intra-erythrocytic growth. Mol Biochem Parasitol 157:137–147
McPherson RA, Donald DR, Sawyer WH et al (1993) Proteolytic digestion of band 3 at an external site alters the erythrocyte membrane organisation and may facilitate malarial invasion. Mol Biochem Parasitol 62:233–242
Li X, Chen H, Oh SS et al (2008) A Presenilin-like protease associated with Plasmodium falciparum micronemes is involved in erythrocyte invasion. Mol Biochem Parasitol 158:22–31
Li X, Chen H, Bahamontes-Rosa N et al (2009) Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria. Biochem Biophys Res Commun 380:454–459
Marapana DS, Wilson DW, Zuccala ES et al (2012) Malaria parasite signal peptide peptidase is an ER-resident protease required for growth but not for invasion. Traffic 13:1457–1465
Chang HH, Falick AM, Carlton PM et al (2008) N-terminal processing of proteins exported by malaria parasites. Mol Biochem Parasitol 160:107–115
Boddey JA, Moritz RL, Simpson RJ et al (2009) Role of the Plasmodium export element in trafficking parasite proteins to the infected erythrocyte. Traffic 10:285–299
Boddey JA, Hodder AN, Gunther S et al (2010) An aspartyl protease directs malaria effector proteins to the host cell. Nature 463:627–631
Klemba M, Gluzman I, Goldberg DE (2004) A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. J Biol Chem 279:43000–43007
Acknowledgements
The Malaria Group at ICGEB is supported by Program Support Grant from Department of Biotechnology, Govt. of India, and research grant to AM under Indo-Swiss Joint Research Programme from Department of Science & Technology, Govt. of India. AM is a recipient of National Bioscience Award for Career Development from Department of Biotechnology, Govt. of India.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rathore, S., Jain, S., Asad, M., Datta, G., Malhotra, P., Mohmmed, A. (2013). Role of Proteases During Intra-erythrocytic Developmental Cycle of Human Malaria Parasite Plasmodium falciparum . In: Chakraborti, S., Dhalla, N. (eds) Proteases in Health and Disease. Advances in Biochemistry in Health and Disease, vol 7. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9233-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9233-7_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9232-0
Online ISBN: 978-1-4614-9233-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)